3D Bioprinter! The Chinese company Revotek, located in Chengdu in southwest China, recently announced that their 3D bioprinter can print real blood vessels and even various types of cells. According to the company’s chairman Yang Keng, this is a complete breakthrough in stem cell research. “This means that the Revotek 3D bioprinting system for 3D printing stem cells has now been completed.”
3D Bioprinter
At the center of this technology is Biosynsphere, a stem cell creation system aimed at developing personalized cells for organ regeneration. In combination with other materials, this 3D bioprinter creates layered cell structures that can be cultivated to form tissues with physiological functions. The 3D printer currently includes two print heads that operate alternately. It prints extremely fast — for example, when 3D printing blood vessels 10 cm long, it completes them in just two minutes.
3D Bioprinter
In the near future, Revotek plans to invest in companies worldwide as well as acquire businesses. They aim to bring 3D bioprinting into medicine, regenerative drugs, and to provide the necessary staff, technology, and laboratories. As part of a press conference, Revotek also signed a cooperation agreement with the University of Dundee in the UK. Professor Sir Alfred Cuschieri, the developer of minimally invasive surgery technology, announced that he will expand cooperation in New York, Hong Kong, Singapore, and other research centers.
Jim Rogers.
3D Bioprinter
Not long ago, Revotek was also visited by Jim Rogers, founder of the Quantum Fund investment fund. He expressed particular interest in bioprinting. “3D bioprinting covers much more, and its high-tech features may become the focus of future investments. This will lead to a revolutionary breakthrough in tissue engineering, regenerative medicine, and medical research.”
Leave a Comment